Literature DB >> 19336503

Head and neck paragangliomas in von Hippel-Lindau disease and multiple endocrine neoplasia type 2.

Carsten C Boedeker1, Zoran Erlic, Stéphane Richard, Udo Kontny, Anne-Paule Gimenez-Roqueplo, Alberto Cascon, Mercedes Robledo, José M de Campos, Francien H van Nederveen, Ronald R de Krijger, Nelly Burnichon, José Gaal, Martin A Walter, Kirsten Reschke, Thorsten Wiech, Johannes Weber, Klaus Rückauer, Pierre Francois Plouin, Vincent Darrouzet, Sophie Giraud, Charis Eng, Hartmut P H Neumann.   

Abstract

BACKGROUND: Head and neck paragangliomas (HNPs) occur as sporadic or familial entities, the latter mostly in association with germline mutations of the SDHB, SDHC, or SDHD (SDHx) genes. Heritable non-SDHx HNP might occur in von Hippel-Lindau disease (VHL, VHL gene), multiple endocrine neoplasia type 2 (MEN2, RET gene), and neurofibromatosis type 1 (NF1, NF1 gene). Reports of non-SDHx HNP presentations are scarce and guidance for genetic testing nonexistent. PATIENTS AND METHODS: An international consortium registered patients with HNPs and performed mutation analyses of the SDHx, VHL, and RET genes. Those with SDHx germline mutations were excluded for purposes of this study. Personal and family histories were evaluated for paraganglial tumors, for the major tumor manifestations, and for family history of VHL, MEN2, or NF1.
RESULTS: Twelve patients were found to have hereditary non-SDHx HNPs of a total of 809 HNP and 2084 VHL registrants, 11 in the setting of germline VHL mutations and one of a RET mutation. The prevalence of hereditary HNP is five in 1000 VHL patients and nine in 1000 non-SDHx HNP patients. Comprehensive literature review revealed previous reports of HNPs in five VHL, two MEN2, and one NF1 patient. Overall, 11 here presented HNP cases, and four previously reported VHL-HNPs had lesions characteristic for VHL and/or a positive family history for VHL.
CONCLUSIONS: Our observations provide evidence that molecular genetic testing for VHL or RET germline mutations in patients with HNP should be done only if personal and/or family history shows evidence for one of these syndromes.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19336503      PMCID: PMC2690424          DOI: 10.1210/jc.2009-0354

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  26 in total

1.  Mutations in SDHD, a mitochondrial complex II gene, in hereditary paraganglioma.

Authors:  B E Baysal; R E Ferrell; J E Willett-Brozick; E C Lawrence; D Myssiorek; A Bosch; A van der Mey; P E Taschner; W S Rubinstein; E N Myers; C W Richard; C J Cornelisse; P Devilee; B Devlin
Journal:  Science       Date:  2000-02-04       Impact factor: 47.728

2.  Gene mutations in the succinate dehydrogenase subunit SDHB cause susceptibility to familial pheochromocytoma and to familial paraganglioma.

Authors:  D Astuti; F Latif; A Dallol; P L Dahia; F Douglas; E George; F Sköldberg; E S Husebye; C Eng; E R Maher
Journal:  Am J Hum Genet       Date:  2001-06-12       Impact factor: 11.025

3.  Germ-line mutations in nonsyndromic pheochromocytoma.

Authors:  Hartmut P H Neumann; Birke Bausch; Sarah R McWhinney; Bernhard U Bender; Oliver Gimm; Gerlind Franke; Joerg Schipper; Joachim Klisch; Carsten Altehoefer; Klaus Zerres; Andrzej Januszewicz; Charis Eng; Wendy M Smith; Robin Munk; Tanja Manz; Sven Glaesker; Thomas W Apel; Markus Treier; Martin Reineke; Martin K Walz; Cuong Hoang-Vu; Michael Brauckhoff; Andreas Klein-Franke; Peter Klose; Heinrich Schmidt; Margarete Maier-Woelfle; Mariola Peçzkowska; Cesary Szmigielski; Charis Eng
Journal:  N Engl J Med       Date:  2002-05-09       Impact factor: 91.245

4.  Late-onset optic atrophy, ataxia, and myopathy associated with a mutation of a complex II gene.

Authors:  M A Birch-Machin; R W Taylor; B Cochran; B A Ackrell; D M Turnbull
Journal:  Ann Neurol       Date:  2000-09       Impact factor: 10.422

5.  Mutations in SDHC cause autosomal dominant paraganglioma, type 3.

Authors:  S Niemann; U Müller
Journal:  Nat Genet       Date:  2000-11       Impact factor: 38.330

Review 6.  A role for mitochondrial enzymes in inherited neoplasia and beyond.

Authors:  Charis Eng; Maija Kiuru; Magali J Fernandez; Lauri A Aaltonen
Journal:  Nat Rev Cancer       Date:  2003-03       Impact factor: 60.716

7.  Distinct clinical features of paraganglioma syndromes associated with SDHB and SDHD gene mutations.

Authors:  Hartmut P H Neumann; Christian Pawlu; Mariola Peczkowska; Birke Bausch; Sarah R McWhinney; Mihaela Muresan; Mary Buchta; Gerlind Franke; Joachim Klisch; Thorsten A Bley; Stefan Hoegerle; Carsten C Boedeker; Giuseppe Opocher; Jörg Schipper; Andrzej Januszewicz; Charis Eng
Journal:  JAMA       Date:  2004-08-25       Impact factor: 56.272

8.  Clinical predictors for germline mutations in head and neck paraganglioma patients: cost reduction strategy in genetic diagnostic process as fall-out.

Authors:  Hartmut P H Neumann; Zoran Erlic; Carsten C Boedeker; Lisa A Rybicki; Mercedes Robledo; Mario Hermsen; Francesca Schiavi; Maurizio Falcioni; Pingling Kwok; Catherine Bauters; Karen Lampe; Markus Fischer; Emily Edelman; Diana E Benn; Bruce G Robinson; Stefanie Wiegand; Gerd Rasp; Boris A Stuck; Michael M Hoffmann; Maren Sullivan; Maria A Sevilla; Marjan M Weiss; Mariola Peczkowska; Agata Kubaszek; Pascal Pigny; Robyn L Ward; Diana Learoyd; Michael Croxson; Dmitry Zabolotny; Svetlana Yaremchuk; Wolfgang Draf; Mihaela Muresan; Robert R Lorenz; Stephan Knipping; Michael Strohm; Gerhard Dyckhoff; Christoph Matthias; Nicole Reisch; Simon F Preuss; Dirk Esser; Martin A Walter; Holger Kaftan; Timo Stöver; Christian Fottner; Harald Gorgulla; Mahdi Malekpour; Masoud Motasaddi Zarandy; Jörg Schipper; Christoph Brase; Alexander Glien; Matthias Kühnemund; Sven Koscielny; Peter Schwerdtfeger; Matti Välimäki; Witold Szyfter; Ulrich Finckh; Klaus Zerres; Alberto Cascon; Giuseppe Opocher; Gerd J Ridder; Andrzej Januszewicz; Carlos Suarez; Charis Eng
Journal:  Cancer Res       Date:  2009-04-07       Impact factor: 12.701

9.  Solid renal tumor severity in von Hippel Lindau disease is related to germline deletion length and location.

Authors:  Jodi K Maranchie; Anoushka Afonso; Paul S Albert; Sivaram Kalyandrug; John L Phillips; Shubo Zhou; James Peterson; Bijan M Ghadimi; Katheen Hurley; Joseph Riss; James R Vasselli; Thomas Ried; Berton Zbar; Peter Choyke; McClellan M Walther; Richard D Klausner; W Marston Linehan
Journal:  Hum Mutat       Date:  2004-01       Impact factor: 4.878

10.  Metastatic carotid body paraganglioma in von Hippel-Lindau disease. An electron microscopic study.

Authors:  M T Hull; L M Roth; J L Glover; P D Walker
Journal:  Arch Pathol Lab Med       Date:  1982-05       Impact factor: 5.534

View more
  26 in total

Review 1.  An update on the genetics of pheochromocytoma.

Authors:  D Karasek; U Shah; Z Frysak; C Stratakis; K Pacak
Journal:  J Hum Hypertens       Date:  2012-05-31       Impact factor: 3.012

Review 2.  Pheochromocytoma/Paraganglioma: Is This a Genetic Disorder?

Authors:  Lauren Fishbein
Journal:  Curr Cardiol Rep       Date:  2019-07-31       Impact factor: 2.931

Review 3.  Pheochromocytoma and paraganglioma: understanding the complexities of the genetic background.

Authors:  Lauren Fishbein; Katherine L Nathanson
Journal:  Cancer Genet       Date:  2012 Jan-Feb

Review 4.  PRECISION MEDICINE: AN UPDATE ON GENOTYPE/BIOCHEMICAL PHENOTYPE RELATIONSHIPS IN PHEOCHROMOCYTOMA/PARAGANGLIOMA PATIENTS.

Authors:  Garima Gupta; Karel Pacak
Journal:  Endocr Pract       Date:  2017-03-23       Impact factor: 3.443

5.  Identification of three new variants of SDHx genes in a cohort of Portuguese patients with extra-adrenal paragangliomas.

Authors:  R Domingues; P Montalvão; M Magalhães; R Santos; L Duarte; M J Bugalho
Journal:  J Endocrinol Invest       Date:  2012-01-30       Impact factor: 4.256

6.  [Hereditary head and neck tumors].

Authors:  S Schwarz-Furlan; C Brase; P Stockmann; I Furlan; A Hartmann
Journal:  Pathologe       Date:  2010-10       Impact factor: 1.011

Review 7.  Genetic testing for pheochromocytoma.

Authors:  David Karasek; Zdenek Frysak; Karel Pacak
Journal:  Curr Hypertens Rep       Date:  2010-12       Impact factor: 5.369

8.  A systematic review on the genetic analysis of paragangliomas: primarily focused on head and neck paragangliomas.

Authors:  A Guha; Z Musil; A Vicha; T Zelinka; K Pacak; J Astl; M Chovanec
Journal:  Neoplasma       Date:  2019-06-29       Impact factor: 2.575

9.  Genetic testing in head and neck paraganglioma: who, what, and why?

Authors:  Shankar K Sridhara; Murat Yener; Ehab Y Hanna; Thereasa Rich; Camilo Jimenez; Michael E Kupferman
Journal:  J Neurol Surg B Skull Base       Date:  2013-04-12

10.  First report of bilateral pheochromocytoma in the clinical spectrum of HIF2A-related polycythemia-paraganglioma syndrome.

Authors:  David Taïeb; Chunzhang Yang; Blandine Delenne; Zhengping Zhuang; Anne Barlier; Fréderic Sebag; Karel Pacak
Journal:  J Clin Endocrinol Metab       Date:  2013-03-28       Impact factor: 5.958

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.